Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Innovative Cellular Therapeutics Holdings Ltd
10% owner at Lyell Immunopharma. Filing since 16 Jul 2026.
CIK 0002095697
Company
Date
Role
Action
Shares
Amount
Of holding
LYEL
Lyell Immunopharma, Inc.
17 Jul 2026
10% owner
Sold on a plan
10
$137.00
0.0%
LYEL
Lyell Immunopharma, Inc.
16 Jul 2026
10% owner
Sold on a plan
10
$137.30
0.0%
2 decisions on file.